In July, the European Commission’s Committee on Scientific Emerging Newly Identified Health Risks (SCENIHR) proposed guidance on medical devices making use of nanomaterials. Many of the risks of nanoparticles to the environment and human health are not known, and SCENIHR’s recommendations aim to learn about these risks while minimizing them. Five phases are proposed for […]
Two separate research groups have completed MS-based maps of human-protein expression, cataloging nearly all the proteins expressed in the human body. Each paper was published in Nature. Combined, the two groups reported more than 70 million mass spectra. Each study documented more than 17,000 proteins encoded by distinct genes. The Human Proteome Map created by […]
BASF once again topped Chemical & Engineering News’s annual ranking of the top 50 global chemical firms. The German company’s $78.6 billion chemical sales in 2013 dominated, outdistancing the second-largest firm, China’s Sinopec, which had 2013 revenues of $60.8 billion. Sinopec rose to the number-two spot this year, overtaking Dow Chemical. Another change among the […]
The FDA will begin regulating laboratory-developed tests (LDTs), it announced at the end of July. To present, the agency has used “enforcement discretion,” and generally not imposed regulation on LDTs, despite their being considered medical devices. According to the FDA, changes in the LDT market over time without oversight might now expose patients to risk. […]
Second quarter revenues for IBO’s Laboratory Instrument Sales Index grew 4.8%, 4.3% excluding currency, to $6,259 million. Organic sales growth was driven by strong results from HORIBA, Illumina and Thermo Fisher Scientific. Operating profit advanced 10.5% to $1,324 million. Operating margin expanded 70 basis points to 18.4% of sales. Modest growth estimates are included for […]
Tokyo, Japan 8/4/14; Sedgefield, UK 8/5/14—Publicly held Japanese firm ReproCELL, a supplier of iPSC-derived products, and media and reagents for cell culture, has acquired UK-based Reinnervate and US-based BioServe Biotechnologies for an undisclosed amount. Reinnervate provides 3-D cell-culture products. BioServe supplies human tissue and other biological samples. “The ReproCELL group of companies now offers products […]
Purmerend, Amsterdam 7/1/14—Midmarket buyout firm AAC Capital has acquired a majority interest in Hobré Instruments from Parcom Capital. Hobré’s management team has also invested in the firm. Hobré designs and manufactures online analyzers, sample systems and turnkey systems for the oil and gas, and process industries. The company has annual revenues of €20 million ($27 […]
Bergisch Gladbach, Germany 8/14/14—Miltenyi Biotech, a provider of products and services for biomedical research and cellular therapy, has acquired Lentigen’s lentiviral-vector–manufacturing business and related assets, including intellectual property and process technologies. The purchase price was not disclosed. “It is our goal at Miltenyi Biotec to become the major supplier of lentiviral vectors for cell and […]
Berwyn, PA 8/5/14—AMETEK has purchased Amptek, a provider of x-ray detectors for XRF systems, electronics for nuclear and spaceflight instruments, and gamma-ray detectors. Financial details were not provided. Amptek has annual revenues of $30 million. “Its products and technology nicely complement our existing materials-analysis capabilities,” stated AMETEK Chairman and CEO Frank S. Hermance. “They also […]
Jena, Germany 8/13/14; Jena, Germany 8/14/14—Analytik Jena has agreed to acquire Bruker’s ICP-MS business and assets (see IBO 7/31/14) for an undisclosed amount. The business generated $12 million in revenues in 2013. “With the acquisition of the ICP-MS business from Bruker, we expect to close an important technological gap and will be in position to […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
